EGI
VIVO

EAM Global Investors’s Meridian Bioscience Inc VIVO Stock Holding History

EAM Global Investors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-86,433
Closed -$2.63M – 269
2022
Q2 		$2.63M Buy
+86,433
New +$2.34M 0.65% 42
2020
Q3 		– Sell
-126,769
Closed -$2.95M – 187
2020
Q2 		$2.95M Buy
+126,769
New +$1.84M 1.33% 9

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM Global Investors's VIVO Position: Q3 2022 in Review

EAM Global Investors sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 86,433 shares — an estimated $2.63M sold.

EAM Global Investors first reported a position in VIVO in Q2 2020 and held it in 2 quarters. The position peaked at $2.95M in Q2 2020. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • EAM Global Investors reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • EAM Global Investors sold 86,433 Meridian Bioscience Inc shares in Q3 2022, an estimated $2.63M.
  • EAM Global Investors first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 2 quarters.
  • EAM Global Investors's Meridian Bioscience Inc position peaked at $2.95M in Q2 2020.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on EAM Global Investors's 13F filing for Q3 2022, filed 14 Nov 2022.